Key player · Company profile

UCB

Named as a key player in 165 of our reports, across 33 regions and countries.

Where they show up

  • Pharmaceuticals165

Geographies

UCB's markets

Markets where UCB is a key player, with the world market size
MarketCategoryWorld sizeGrowth
Hidradenitis Suppurativa Treatment PharmaceuticalsIn full reportIn full report
Myasthenia Gravis Treatment PharmaceuticalsIn full reportIn full report
Osteoporosis Drugs PharmaceuticalsIn full reportIn full report
Parkinson's Disease Treatment PharmaceuticalsIn full reportIn full report
Psoriasis Treatment PharmaceuticalsIn full reportIn full report

Companies they compete with most

Named as key players in the same markets as UCB (number of shared markets).

AbbVie Inc.3 shared markets Amgen Inc.3 shared markets Novartis AG3 shared markets Eli Lilly and Company2 shared markets Johnson & Johnson2 shared markets Amneal Pharmaceuticals, Inc1 shared market argenx1 shared market AstraZeneca1 shared market

Recent reports naming UCB

Search all reports for UCB All companies